In hospitalized pneumonia, most tests still find no pathogen
Pneumonia inflames the lung’s alveoli, bringing cough, chest pain, fever, and hard breathing in shifting mixes. Each year it hits about 450 million people—roughly 7% of the world—and causes about 4 million deaths. Yet in a large U.S. hospital study, 62% of tested patients had no detectable germ.
Infection is usually viral or bacterial, less often other microbes; naming the culprit is hard. Clinicians lean on symptoms, exam, X-rays, blood work, and sputum culture, and classify cases by where they began—community, hospital, or healthcare-associated. Risk rises with cystic fibrosis, COPD, sickle cell disease, asthma, diabetes, heart failure, smoking, weak cough after stroke, and immunodeficiency. Vaccines exist against some Streptococcus pneumoniae strains, influenza, and SARS-CoV-2; hand washing, treating worsening breathing symptoms promptly, and not smoking also help. Suspected bacterial cases get antibiotics; severe illness may mean hospital care and oxygen if levels fall. Antibiotics and vaccines improved twentieth-century survival, yet pneumonia still leads death lists in developing countries and among the very old, very young, and chronically ill.
Adults often show productive cough, shaking chills, shortness of breath, stabbing pain on deep breaths, and fast breathing; confusion may dominate in the elderly. Children under five typically have fever, cough, and fast or difficult breathing—though fever can be missing in severe disease, malnutrition, or old age, and cough may be absent under two months. Classic clues are imperfect: Legionella with abdominal pain or diarrhea, pneumococcus with rusty sputum, Klebsiella with "currant jelly" blood, Mycoplasma with neck nodes or ear infection, viruses with more wheezing. The old typical-versus-atypical split is no longer emphasized. Mixed viral-bacterial infection may occur in roughly 45% of childhood and 15% of adult cases; about half the time no agent is isolated despite careful testing.
Surveillance in five Chicago and Nashville hospitals (January 2010–June 2012) found 2,259 radiographic pneumonia cases with testable specimens: 62% had no pathogen, viruses outran bacteria (23% versus 11%), 3% had both, and 1% fungal or mycobacterial. Top detections were human rhinovirus (9%), influenza (6%), and S. pneumoniae (5%). Community-acquired bacterial disease still often features S. pneumoniae (nearly 50% of isolates in some series), with Haemophilus, Chlamydophila, and Mycoplasma also common; drug-resistant pneumococcus and MRSA are rising. Acid-suppressing drugs associate with higher risk; about 10% of ventilated patients develop ventilator-associated pneumonia. Fungal forms cluster in immunocompromised hosts; parasites usually reach lungs secondarily. Microaspiration of contaminated secretions seeds lower airways—progress hinging on virulence, dose, and immune phenotype.
Source: Pneumonia
